AbbVie Inc. (ABBV) vs Gilead Sciences, Inc. (GILD)
A side-by-side comparison of AbbVie Inc. and Gilead Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
ABBV
AbbVie Inc.
$257.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
GILD
Gilead Sciences, Inc.
$143.72HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — ABBV vs GILD
growth of $100 · dividends reinvested · last 10yABBV +507.0% (+19.8%/yr)GILD +161.3% (+10.1%/yr)ABBV compounded faster over this window
ABBV GILD
ABBV vs GILD: by the numbers
- •ABBV is the larger company ($454.17B vs $178.44B market cap).
- •ABBV is profitable (9.81% net margin) while GILD runs a net loss (-10.64%).
- •ABBV grew revenue faster over the past five years (3.69% vs 2.72% CAGR).
- •ABBV pays the higher dividend yield (2.68% vs 2.22%).
Metrics side by side
Valuation
| Metric | ABBV | GILD |
|---|---|---|
| P/E ratio | 72.43 | N/A |
| Forward P/E | 18.32 | N/A |
| P/S ratio | 7.05 | 5.86 |
| P/B ratio | N/A | 15.09 |
| EV / EBITDA | 19.34 | N/A |
| FCF yield | 3.99% | 7.27% |
Profitability
| Metric | ABBV | GILD |
|---|---|---|
| Gross margin | 71.48% | 79.59% |
| Operating margin | 29.32% | 39.74% |
| Net margin | 9.81% | -10.64% |
| ROE | N/A | -27.39% |
| ROIC | 13.46% | -3.66% |
Dividends
| Metric | ABBV | GILD |
|---|---|---|
| Dividend yield | 2.68% | 2.22% |
| Payout ratio | 192.43% | N/A |
Growth (annualized)
| Metric | ABBV | GILD |
|---|---|---|
| Revenue CAGR (5Y) | 3.69% | 2.72% |
| EPS CAGR (5Y) | -2.79% | 133.83% |
| FCF CAGR (5Y) | 0.11% | 9.27% |
| Total return CAGR (5Y) | 23.51% | 19.60% |
Frequently asked
- Which has grown faster, ABBV or GILD?
- Over the past five years, ABBV grew revenue faster — ABBV at a 3.69% CAGR versus GILD at 2.72%.
- Does ABBV or GILD pay a bigger dividend?
- ABBV yields 2.68% and GILD yields 2.22% based on trailing dividends and the latest price.
- Is ABBV or GILD more profitable?
- ABBV runs the higher net margin — ABBV at 9.81% versus GILD at -10.64%.
- How have ABBV and GILD total returns compared?
- Over the past 10 years, ABBV delivered 19.76% and GILD delivered 10.21% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioAbbVie dividend yieldGilead Sciences dividend yieldAbbVie ROEGilead Sciences ROEAbbVie operating marginGilead Sciences operating marginAbbVie revenue growthGilead Sciences revenue growthAbbVie free cash flowGilead Sciences free cash flow
AbbVie & Gilead Sciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.